Skip to search formSkip to main contentSkip to account menu

trimazosin

Known as: 2-hydroxy-2-methylpropyl 4-(4-amino-6,7,8-trimethoxy-2-quinqzolinyl)-1-piperazinecar boxylate, 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2- methylpropyl ester 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Adrenergic alpha-1 Receptor AntagonistsAntihypertensive AgentsPiperazinesVasodilator Agents

Narrower (1)

trimazosin hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levels.
The effects on plasma lipids, blood glucose and serum insulin levels of oral administration of trimazosin and pindolol over a 6… 
1986
1986
Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.
The possible racial differences in alpha 1-adrenoceptor responsiveness and the blood pressure and heart rate responses following… 
1985
1985
Trimazosin: Relationships Between Hypotensive Effect, Vascular Responsiveness, and Drug and Metabolite Concentrations
Summary: The relationships between the effects on blood pressure and vascular responsiveness, and the whole blood concentration… 
1984
1984
The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
Trimazosin is a quinazoline antihypertensive agent structurally related to the selective alpha 1-adrenoceptor blocker prazosin… 
1984
1984
Haemodynamic Effects of Selective α1Blockade (Trimazosin) in Essential Hypertension
As a preliminary to a larger clinical trial, the haemodynamic effects of the selective α-adrenoceptor antagonist trimazosin were… 
1984
1984
Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
As a preliminary to a larger clinical trial, the haemodynamic effects of the selective alpha 1-adrenoceptor antagonist trimazosin… 
1981
1981
Treatment of refractory heart failure with trimazosin.
Seven patients with severe heart failure resistant to conventional treatment with digoxin and diuretics were given trimazosin, a… 
1980
1980
Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
Trimazosin was administered for 2 days in doses-ranging from 50 to 200 mg to 16 patients with essential hypertension. The… 
1975
1975
Treatment of essential hypertension with trimazosin, a new vasodilator agent.
1973
1973
The effect of trimazosin in essential hypertension.